A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
Clinical trial NCT05180799 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05180799
- Sponsor
- BioAtla, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-03
- Primary completion
- 2025-03-19
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.